NervGen Pharma Corp. (NGEN)
1.78
+0.02
(+1.14%)
USD |
NASDAQ |
Oct 02, 16:00
1.82
+0.04
(+2.25%)
After-Hours: 20:00
NervGen Pharma EPS Diluted (Quarterly) : -0.2283 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2283 |
| March 31, 2026 | -0.0153 |
| December 31, 2025 | -0.251 |
| September 30, 2025 | -0.0413 |
| June 30, 2025 | -0.0914 |
| March 31, 2025 | -0.0389 |
| December 31, 2024 | -0.0875 |
| September 30, 2024 | -0.0554 |
| June 30, 2024 | -0.0818 |
| March 31, 2024 | -0.0289 |
| December 31, 2023 | -0.106 |
| September 30, 2023 | -0.054 |
| June 30, 2023 | -0.0599 |
| March 31, 2023 | -0.0591 |
| December 31, 2022 | -0.0744 |
| September 30, 2022 | -0.046 |
| June 30, 2022 | -0.1047 |
| March 31, 2022 | -0.0848 |
| December 31, 2021 | -0.0714 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.0712 |
| June 30, 2021 | -0.0591 |
| March 31, 2021 | -0.05 |
| December 31, 2020 | -0.0998 |
| September 30, 2020 | -0.0478 |
| June 30, 2020 | -0.0624 |
| March 31, 2020 | -0.047 |
| December 31, 2019 | -0.0758 |
| September 30, 2019 | -0.0634 |
| June 30, 2019 | -0.0412 |
| March 31, 2019 | -0.1177 |
| December 31, 2018 | -0.0214 |
| September 30, 2018 | -0.0145 |
| June 30, 2018 | -0.0021 |
| March 31, 2018 | -0.0003 |
| December 31, 2017 | -0.0002 |
| September 30, 2017 | -0.0001 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -0.0001 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -1.434 |
| Milestone Pharmaceuticals, Inc. | -0.2063 |
| Clearmind Medicine, Inc. | -0.5734 |
| Lexaria Bioscience Corp. | -1.204 |
| Target Group, Inc. (Canada) | -0.0004 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.10M |
| Total Expenses (Quarterly) | 21.10M |
| Enterprise Value | 128.24M |
| Earnings Yield | -30.11% |
| Normalized Earnings Yield | -19.56 |